These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10027863)

  • 1. Angiotensin receptor subtype 1 mediates angiotensin II enhancement of isoproterenol-induced cyclic AMP production in preglomerular microvascular smooth muscle cells.
    Inoue T; Mi Z; Gillespie DG; Dubey RK; Jackson EK
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1229-34. PubMed ID: 10027863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation by angiotensin II of isoproterenol-induced cAMP production in preglomerular microvascular smooth muscle cells from normotensive and genetically hypertensive rats.
    Mokkapatti R; Vyas SJ; Romero GG; Mi Z; Inoue T; Dubey RK; Gillespie DG; Stout AK; Jackson EK
    J Pharmacol Exp Ther; 1998 Oct; 287(1):223-31. PubMed ID: 9765341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase C and Src modulate angiotensin II-induced cyclic AMP production in preglomerular microvascular smooth-muscle cells from spontaneously hypertensive rats.
    Jackson EK; Gillespie DG; Jackson TC
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):106-10. PubMed ID: 17312452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II effects on second messengers involved in prolactin secretion are mediated by AT1 receptor in anterior pituitary cells.
    Moreau C; Rasolonjanahary R; Audinot V; Kordon C; Enjalbert A
    Mol Cell Neurosci; 1994 Dec; 5(6):597-603. PubMed ID: 7704434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced levels of cyclic AMP contribute to the enhanced oxidative stress in vascular smooth muscle cells from spontaneously hypertensive rats.
    Saha S; Li Y; Anand-Srivastava MB
    Can J Physiol Pharmacol; 2008 Apr; 86(4):190-8. PubMed ID: 18418428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II potentiates vasodilation of rat aorta by cAMP elevating agonists.
    Brizzolara-Gourdie A; Webb JG
    J Pharmacol Exp Ther; 1997 Apr; 281(1):354-9. PubMed ID: 9103517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AT1 receptors and L-type calcium channels: functional coupling in supersensitivity to angiotensin II in diabetic rats.
    Arun KH; Kaul CL; Ramarao P
    Cardiovasc Res; 2005 Feb; 65(2):374-86. PubMed ID: 15639476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists.
    Cosentino F; Savoia C; De Paolis P; Francia P; Russo A; Maffei A; Venturelli V; Schiavoni M; Lembo G; Volpe M
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):493-9. PubMed ID: 15831358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells.
    Nickenig G; Murphy TJ
    Mol Pharmacol; 1996 Oct; 50(4):743-51. PubMed ID: 8863818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Both subtype 1 and 2 receptors of angiotensin II participate in regulation of intracellular calcium in glomerular epithelial cells.
    Sharma R; Sharma M; Vamos S; Savin VJ; Wiegmann TB
    J Lab Clin Med; 2001 Jul; 138(1):40-9. PubMed ID: 11433227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AT2 receptors attenuate AT1 receptor-induced phospholipase D activation in vascular smooth muscle cells.
    Andresen BT; Romero GG; Jackson EK
    J Pharmacol Exp Ther; 2004 Apr; 309(1):425-31. PubMed ID: 14722318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II inhibits glomerular adenylate cyclase via the angiotensin II receptor subtype 1 (AT1).
    Edwards RM; Stack EJ
    J Pharmacol Exp Ther; 1993 Aug; 266(2):506-10. PubMed ID: 8394907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lower ratio of AT1/AT2 receptors of angiotensin II is found in female than in male spontaneously hypertensive rats.
    Silva-Antonialli MM; Tostes RC; Fernandes L; Fior-Chadi DR; Akamine EH; Carvalho MH; Fortes ZB; Nigro D
    Cardiovasc Res; 2004 Jun; 62(3):587-93. PubMed ID: 15158151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of angiotensin II on stimulus-induced release of cAMP is augmented in the genetically hypertensive rat kidney.
    Vyas SJ; Mi Z; Jackson EK
    J Pharmacol Exp Ther; 1996 Oct; 279(1):114-9. PubMed ID: 8858983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prejunctional AT(1) receptor subtype-dependent modification of neurotransmitter releases in canine isolated splenic arteries.
    Komiyama J; Yang XP; Chiba S
    Auton Autacoid Pharmacol; 2003; 23(5-6):297-305. PubMed ID: 15255814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tonic suppression of spontaneous baroreceptor reflex by endogenous angiotensins via AT(2) subtype receptors at nucleus reticularis ventrolateralis in the rat.
    Lin K; Chan SH; Chan JY
    Synapse; 2001 Apr; 40(1):85-94. PubMed ID: 11170225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic AMP-mediated inhibition of angiotensin II-induced protein synthesis is associated with suppression of tyrosine phosphorylation signaling in vascular smooth muscle cells.
    Giasson E; Servant MJ; Meloche S
    J Biol Chem; 1997 Oct; 272(43):26879-86. PubMed ID: 9341120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells.
    Esteban V; Ruperez M; Sánchez-López E; Rodríguez-Vita J; Lorenzo O; Demaegdt H; Vanderheyden P; Egido J; Ruiz-Ortega M
    Circ Res; 2005 May; 96(9):965-73. PubMed ID: 15831814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II activates intermediate-conductance Ca2+ -activated K+ channels in arterial smooth muscle cells.
    Hayabuchi Y; Nakaya Y; Yasui S; Mawatari K; Mori K; Suzuki M; Kagami S
    J Mol Cell Cardiol; 2006 Dec; 41(6):972-9. PubMed ID: 16919291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular vasopressin receptors mediate inhibition of beta adrenergic receptor-induced cyclic AMP accumulation.
    Nambi P; Whitman M; Stassen FL; Crooke ST
    J Pharmacol Exp Ther; 1986 Apr; 237(1):143-6. PubMed ID: 3007735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.